Company name | Market Cap | Net Debt | Health score | Current ratio | Quick ratio | Net Debt to FCF | FCF to Interest | Intangibles as % of Total Assets | Total Debt to Equity |
$237.5B | $7,054.0M | 6.8 | 1.7x | 1.2x | 1.1x | 16.0x | 8.2% | 31.4% | |
$145.9B | $10.7B | 5.9 | 1.1x | 0.5x | 4.4x | 8.0x | 17.0% | 50.7% | |
$144.5B | $7,786.0M | 5.2 | 1.9x | 1.1x | 2.2x | N/A | 0.0% | 28.4% | |
$121.2B | $25.4B | 6.4 | 1.9x | 0.6x | 4.6x | 7.2x | 13.5% | 53.6% | |
$41.5B | ($3,275.9M) | 6.5 | 4.2x | 3.1x | (11.3x) | N/A | 9.0% | 7.0% | |
$31.1B | ($50.5M) | 6.5 | 1.5x | 1.2x | (0.1x) | 32.2x | 1.6% | 120.3% | |
$25.6B | €5,236.0M | 5.0 | 1.2x | 0.7x | 19.1x | 1.0x | 10.3% | 63.4% | |
$22.9B | ($30.2M) | 6.1 | 2.1x | 1.2x | (0.0x) | 7.1x | 19.2% | 1.9% | |
$21.8B | $5,679.1M | 6.4 | 2.9x | 1.3x | 5.0x | 7.3x | 21.5% | 43.0% | |
$17.7B | ($869.6M) | 6.4 | 3.6x | 2.5x | (2.9x) | 8.5x | 0.0% | 6.9% | |
$12.9B | ($955.7M) | 6.3 | 1.2x | 1.0x | (1.5x) | 146.5x | 1.7% | 2.3% |
The Abbott Laboratories (ABT) quick ratio is 1.2x, compared to the industry median of 2.2x and the 5-year historical average of 1.1x.
The Abbott Laboratories (ABT) net debt to FCF ratio is 1.1x, compared to the industry median of 1.0x and the 5-year historical average of (1.6x).
Abbott Laboratories (ABT) FCF to interest ratio is 16.0x, compared to the industry median of 0.2x and the 5-year historical average of 13.0x.
The Abbott Laboratories (ABT) total debt to equity ratio is 31.4%, compared to the industry median of 25.7% and the 5-year historical average of 48.0%.